kbp-7072
Small moleculeexperimental
Clinical trial activity
4 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2015 (NCT02454361)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- 30S ribosomal protein S12INHIBITOR
rpsL inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- kbp-7072
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05507463 | Phase 1 | Aug 16, 2022 | KBP Biosciences, Parexel |
| NCT04532957 | Phase 1 | Aug 11, 2020 | Covance, KBP Biosciences |
| NCT02654626 | Phase 1 | Oct 1, 2015 | KBP Biosciences |
| NCT02454361 | Phase 1 | May 1, 2015 | KBP Biosciences |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| KBP Biosciences | For profit | 4 | 4 | 1 | 2015 |
| Covance | For profit | 1 | 0 | 1 | 2020 |
| Parexel | For profit | 1 | 0 | 1 | 2022 |
3 organizations
Page 1 / 1